Detalles de la búsqueda
1.
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
Breast Cancer Res
; 21(1): 103, 2019 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31488209
2.
Interaction of acid ceramidase inhibitor LCL521 with tumor response to photodynamic therapy and photodynamic therapy-generated vaccine.
Int J Cancer
; 139(6): 1372-8, 2016 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27136745
3.
Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
J Immunol
; 192(1): 512-22, 2014 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24285836
4.
Immunoregulatory Cell Depletion Improves the Efficacy of Photodynamic Therapy-Generated Cancer Vaccines.
Int J Mol Sci
; 16(11): 27005-14, 2015 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26569233
5.
DNA-PK inhibitor AZD7648 is a more portent radiosensitizer than PARP inhibitor Olaparib in BRCA1/2 deficient tumors.
DNA Repair (Amst)
; 139: 103689, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749239
6.
Radiation and chemo-sensitizing effects of DNA-PK inhibitors are proportional in tumors and normal tissues.
Mol Cancer Ther
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38781104
7.
Detection of FLASH-radiotherapy tissue sparing in a 3D-spheroid model using DNA damage response markers.
Radiother Oncol
; 196: 110326, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735536
8.
DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost.
Sci Rep
; 13(1): 12429, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528151
9.
Radiosensitizing oxygenation changes in murine tumors treated with VEGF-ablation therapy are measurable using oxygen enhanced-MRI (OE-MRI).
Radiother Oncol
; 187: 109795, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414252
10.
Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
Cancer Immunol Immunother
; 61(5): 643-54, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22021068
11.
Residual gammaH2AX foci as an indication of lethal DNA lesions.
BMC Cancer
; 10: 4, 2010 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20051134
12.
gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation.
Clin Cancer Res
; 15(10): 3344-53, 2009 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19401347
13.
A screen for suppressors of gross chromosomal rearrangements identifies a conserved role for PLP in preventing DNA lesions.
PLoS Genet
; 3(8): e134, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17696614
14.
N-dihydrogalactochitosan-supported tumor control by photothermal therapy and photothermal therapy-generated vaccine.
J Photochem Photobiol B
; 204: 111780, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31981988
15.
N-dihydrogalactochitosan as immune and direct antitumor agent amplifying the effects of photodynamic therapy and photodynamic therapy-generated vaccines.
Int Immunopharmacol
; 75: 105764, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31352327
16.
Residual gammaH2AX after irradiation of human lymphocytes and monocytes in vitro and its relation to late effects after prostate brachytherapy.
Radiother Oncol
; 86(3): 336-46, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17904670
17.
Radiosensitization by the histone deacetylase inhibitor PCI-24781.
Clin Cancer Res
; 13(22 Pt 1): 6816-26, 2007 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18006784
18.
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.
Nat Commun
; 8: 14432, 2017 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28211448
19.
DNA-PK is responsible for enhanced phosphorylation of histone H2AX under hypertonic conditions.
DNA Repair (Amst)
; 4(10): 1172-81, 2005 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-16046194
20.
Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays.
Radiother Oncol
; 80(2): 223-9, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16905207